Saint-Petersburg, Russia

Evgenii Jur'evich Smirnov

This inventor holds 1 USPTO granted patent. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evgenii Jur'evich Smirnov. Retrieved from https://idiyas.com/inventor/evgenii-jur-evich-smirnov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Evgenii Jur'evich Smirnov: Innovator in CDK8/19 Inhibitors

Introduction

Evgenii Jur'evich Smirnov is a notable inventor based in St. Petersburg, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit CDK8/19. His work is crucial for advancing treatments for various diseases and disorders.

Latest Patents

Smirnov holds a patent for CDK8/19 inhibitors, which are novel compounds designed to target specific biological pathways. The patent details a pharmaceutical composition that includes these compounds, emphasizing their potential use as a medicine for treating a range of health issues.

Career Highlights

Throughout his career, Smirnov has focused on innovative solutions in the pharmaceutical industry. His research has led to the development of effective compounds that can significantly impact patient care and treatment outcomes.

Collaborations

Smirnov has collaborated with esteemed colleagues, including Aleksei Leonidovich Mindich and Anna Jur'evna Chestnova. These partnerships have enhanced the research and development process, contributing to the success of his inventions.

Conclusion

Evgenii Jur'evich Smirnov is a prominent figure in the field of pharmaceutical innovation, with a focus on CDK8/19 inhibitors. His contributions are paving the way for new treatments that can improve health outcomes for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…